$1.62
0.085.19%
At close: Dec 15, 4:00 PM EST
$1.66
0.042.47%
After Hours: 7:51 PM EST
Comments
Loading...
Inhibikase Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:IKT | Benzinga
Inhibikase Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.130
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Inhibikase Therapeutics using advanced sorting and filters.
Inhibikase Therapeutics (IKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-14 | $-0.13 | $-0.12 | -8.33 % |
| Q2 | 2025-08-14 | $-0.11 | $-0.09 | -22.2 % |
| Q1 | 2025-05-14 | $-0.15 | $-0.11 | -36.4 % |
| Q4 | 2025-03-27 | $0.87 | $-0.10 | 970.0 % |
Inhibikase Therapeutics (IKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2022-11-14 | $7.29K | $200.00K | -96.4 % |
| Q2 | 2022-08-12 | $6.55K | $300.00K | -97.8 % |
| Q1 | 2022-05-16 | $46.03K | $300.00K | -84.7 % |
| Q4 | 2022-03-31 | $1.94M | $300.00K | 548.0 % |
FAQ
When is Inhibikase Therapeutics (NASDAQ:IKT) reporting earnings?
Inhibikase Therapeutics (IKT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2025 for Q3.
What were the latest earnings per share (EPS) for Inhibikase Therapeutics (NASDAQ:IKT)?
Inhibikase Therapeutics (IKT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2025 for Q3 and the Actual EPS was $-0.13, which missed the estimate of $-0.12.
What were Inhibikase Therapeutics’s (NASDAQ:IKT) revenues?
Inhibikase Therapeutics (IKT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2025 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
